3D bioprinting of vascularized cardiac constructs reveals improved cardiomyocyte organization and contractile function
Open Access
- 2 November 2026
- journal article
- research article
- Published by Frontiers Media SA in Journal of Pharmacy & Pharmaceutical Sciences
- Vol. 29, 17204
Abstract
Background: Despite advances in cardiac tissue engineering, generating constructs that simultaneously achieve vascularization and organized cardiomyocyte function remains a major challenge. Methods: In this study, three-dimensional (3D) bioprinting was used to fabricate human umbilical vein endothelial cell (HUVEC)-laden alginate/gelatin constructs with defined architectures designed to mimic myocardial alignment. Constructs were cultured with vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) under static conditions followed by short-term dynamic stimulation in a bioreactor. Cardiomyocytes - H9c2 cells, neonatal rat ventricular myocytes (NRVMs), or human induced pluripotent stem cell–derived cardiomyocytes (iPSC-CMs) - were subsequently seeded onto the constructs. Vascularization and the distribution of cells were assessed using immunofluorescence, and functional activity of cardiomyocytes was evaluated by calcium transient imaging. Results: Bioprinted constructs developed interconnected CD31-positive endothelial networks in response to growth factor supplementation and dynamic culture, whereas control constructs cultured without growth factors or bioreactor exposure showed limited vascular organization. Cardiomyocytes seeded onto vascularized constructs exhibited improved structural organization, including increased alignment and integration with endothelial networks. Functional assessment revealed more synchronized and rhythmic calcium transients compared to non-vascularized constructs. Conclusion: This study demonstrates that combining 3D bioprinting with controlled architectural design and endothelial network formation enhances cardiomyocyte organization and function. These findings highlight the critical role of vascular-like networks in improving the performance of engineered cardiac tissues.Keywords
This publication has 37 references indexed in Scilit:
- Cardiac Tissue Engineering: A Journey from Scaffold Fabrication to In Vitro CharacterizationSmall Science, 2024
- Bioprinting‐Assisted Tissue Assembly for Structural and Functional Modulation of Engineered Heart Tissue Mimicking Left Ventricular Myocardial Fiber OrientationAdvanced Materials, 2024
- 3D Printing Approaches to Engineer Cardiac TissueCurrent Cardiology Reports, 2023
- Vascular cells improve functionality of human cardiac organoidsCell Reports, 2023
- Neonatal rat ventricular myocytes interfacing conductive polymers and carbon nanotubesCell Biology and Toxicology, 2022
- Bioreactors for Cardiac Tissue EngineeringAdvanced Healthcare Materials, 2018
- Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chipBiomaterials, 2016
- Bridge to Removal: A Paradigm Shift for Left Ventricular Assist Device TherapyThe Annals of Thoracic Surgery, 2015
- Vascularization is the key challenge in tissue engineeringAdvanced Drug Delivery Reviews, 2011
- Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitroBiochemical and Biophysical Research Communications, 1992